We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.04%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$47.9B
AUM Growth
-$1.36B
Cap. Flow
-$823M
Cap. Flow %
-1.72%
Top 10 Hldgs %
16.24%
Holding
2,870
New
35
Increased
1,053
Reduced
1,711
Closed
52

Sector Composition

Rank Sector Weight
1 Technology 17.16%
2 Financials 17.12%
3 Healthcare 12.98%
4 Industrials 10.68%
5 Consumer Discretionary 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARQ icon
2576
Arq
ARQ
$88M
$217K ﹤0.01%
19,030
-430
-2% -$4.04K
NAT icon
2577
Nordic American Tanker
NAT
$1.3B
$216K ﹤0.01%
111,256
+9,625
+9% +$22K
NRIM icon
2578
Northrim BanCorp
NRIM
$600M
$214K ﹤0.01%
24,756
+900
+4% +$7.73K
USLM icon
2579
United States Lime & Minerals
USLM
$3.38B
$214K ﹤0.01%
14,635
-625
-4% -$9.4K
ZIXI
2580
DELISTED
Zix Corporation
ZIXI
$214K ﹤0.01%
50,091
-4,550
-8% -$19.5K
CLNE icon
2581
Clean Energy Fuels
CLNE
$414M
$213K ﹤0.01%
129,246
-7,650
-6% -$12.6K
BRG
2582
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$213K ﹤0.01%
25,070
-728
-3% -$6.11K
BCOV
2583
DELISTED
Brightcove, Inc.
BCOV
$212K ﹤0.01%
30,551
-1,075
-3% -$7.48K
CIVI
2584
DELISTED
Civitas Solutions, Inc.
CIVI
$212K ﹤0.01%
13,766
-500
-4% -$7.61K
PI icon
2585
Impinj
PI
$4.99B
$211K ﹤0.01%
16,221
-10
-0.1% -$167
RETA
2586
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$211K ﹤0.01%
10,265
+200
+2% +$5.15K
LCTX icon
2587
Lineage Cell Therapeutics
LCTX
$284M
$209K ﹤0.01%
88,898
+2,257
+3% +$5.29K
ECOM
2588
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$209K ﹤0.01%
22,914
-775
-3% -$7.07K
GHM icon
2589
Graham Corp
GHM
$1.22B
$208K ﹤0.01%
9,706
-375
-4% -$8.04K
APLS
2590
DELISTED
Apellis Pharmaceuticals
APLS
$206K ﹤0.01%
+9,307
New +$183K
MITK icon
2591
Mitek Systems
MITK
$774M
$205K ﹤0.01%
27,705
-1,000
-3% -$8.14K
PACB icon
2592
Pacific Biosciences
PACB
$404M
$205K ﹤0.01%
99,955
-1,155
-1% -$3K
QHC
2593
DELISTED
Quorum Health Corporation
QHC
$205K ﹤0.01%
25,121
+664
+3% +$4.35K
INAP
2594
DELISTED
Internap Corporation
INAP
$205K ﹤0.01%
18,668
+530
+3% +$7.42K
BLMT
2595
DELISTED
BSB Bancorp, Inc.
BLMT
$205K ﹤0.01%
6,692
-425
-6% -$12.8K
SEND
2596
DELISTED
SendGrid, Inc.
SEND
$205K ﹤0.01%
+7,299
New +$189K
HDNG
2597
DELISTED
Hardinge Inc
HDNG
$205K ﹤0.01%
+11,191
New +$204K
PTVCB
2598
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
$204K ﹤0.01%
9,291
-475
-5% -$11K
BREW
2599
DELISTED
Craft Brew Alliance, Inc.
BREW
$204K ﹤0.01%
10,967
-375
-3% -$7.09K
CRCM
2600
DELISTED
CARE.COM, INC.
CRCM
$204K ﹤0.01%
12,533
-275
-2% -$5.04K

Similar funds

RhumbLine Advisers's Q1 2018 Portfolio in Review

As of Q1 2018, RhumbLine Advisers held 2,870 positions worth $47.9B, down 2.8% from $49.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 3%. RhumbLine Advisers opened 35 new positions and exited 52, leaving the 2,870-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 102,040 shares worth $5.39M.
  • RhumbLine Advisers added most to iShares Core US Aggregate Bond ETF in Q1 2018, an estimated $13.1M increase.
  • RhumbLine Advisers's biggest Q1 2018 reduction was Apple, cutting an estimated $47.2M.
  • RhumbLine Advisers fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $14.6M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $47.9B portfolio in Q1 2018.
  • RhumbLine Advisers opened 35 new positions and closed 52 in Q1 2018.
  • RhumbLine Advisers's portfolio value fell 2.8% quarter-over-quarter to $47.9B.

Based on RhumbLine Advisers's 13F filing for Q1 2018, filed 2 May 2018.